CONMED Corporation  

(Public, NASDAQ:CNMD)   Watch this stock  
Find more results for CNMD
44.20
-1.30 (-2.86%)
Jun 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 42.96 - 44.47
52 week 35.51 - 60.66
Open 43.81
Vol / Avg. 290,835.00/210,880.00
Mkt cap 1.22B
P/E 56.24
Div/yield 0.20/1.81
EPS 0.79
Shares 27.75M
Beta 1.01
Inst. own 100%
Jul 19, 2016
Q2 2016 Conmed Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 27, 2016
Conmed Corp Annual Shareholders Meeting (Estimated)
May 25, 2016
Conmed Corp Annual Shareholders Meeting
May 5, 2016
Conmed Corp at Deutsche Bank Health Care Conference - Webcast
Apr 27, 2016
Q1 2016 Conmed Corp Earnings Call - Webcast
Apr 27, 2016
Q1 2016 Conmed Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -1.25% 4.24%
Operating margin 1.95% 7.12%
EBITD margin - 16.58%
Return on average assets -0.74% 2.77%
Return on average equity -1.56% 5.23%
Employees 3,400 -
CDP Score - -

Address

525 French Rd
UTICA, NY 13502-5945
United States - Map
+1-315-6243215 (Phone)
+1-315-7970321 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. Its products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. Its product lines consist of orthopedic surgery, general surgery and surgical visualization. Its orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. Its general surgery product line offers a range of products in the areas of advanced surgical, endoscopic technologies and critical care. Its surgical visualization product line offers imaging systems for use in minimally invasive orthopedic and general surgery procedures. Its products are distributed domestically directly to over 6,000 hospitals and other healthcare institutions, as well as through medical specialty distributors.

Officers and directors

Mark E. Tryniski Independent Chairman of the Board
Age: 55
Bio & Compensation  - Reuters
Curt R. Hartman President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Luke A. Pomilio Chief Financial Officer, Executive Vice President - Finance
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Patrick J. Beyer President - CONMED International
Age: 49
Bio & Compensation  - Reuters
John E. Kennedy Vice President and General Manager - CET
Age: 57
Bio & Compensation  - Reuters
Johonna Pelletier Treasurer and Vice President - Tax
Age: 42
Bio & Compensation  - Reuters
Stanley Peters Vice President and General Manager - Advanced Surgical
Age: 40
Bio & Compensation  - Reuters
Mark D Snyder Executive Vice President - Operations & Business Systems
Age: 62
Bio & Compensation  - Reuters
Daniel S. Jonas Executive Vice President - Legal Affairs, General Counsel
Age: 51
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Heather L. Cohen Executive Vice President - Human Resources, Deputy General Counsel, Secretary
Age: 42
Bio & Compensation  - Reuters